Recent Clinical and Preclinical Advances in External Stimuli-Responsive Therapies for Head and Neck Squamous Cell Carcinoma

Head and neck squamous cell carcinoma (HNSCC) has long been one of the most prevalent cancers worldwide; even though treatments such as surgery, chemotherapy, radiotherapy and immunotherapy have been proven to benefit the patients and prolong their survival time, the overall five-year survival rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Zheng, Yang, Xin, Ainiwaer, Mailudan, Chen, Fei, Liu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821160/
https://www.ncbi.nlm.nih.gov/pubmed/36614974
http://dx.doi.org/10.3390/jcm12010173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821160/
https://www.ncbi.nlm.nih.gov/pubmed/36614974
http://dx.doi.org/10.3390/jcm12010173

Ejemplares similares